MAIA Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
707 State Rd Ste 104, Princeton, New Jer...Phone Number
(609) 436-9148Website
www.maiapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About MAIA Pharmaceuticals
Fosun Pharma specializes in Sincalide for Injection, a cholecystokinin (CCK) analog used primarily in diagnostic imaging. Their Sincalide product is noteworthy for being FDA approved, having a 24-month shelf life, and contains no preservatives or polysorbates. Aimed at healthcare professionals, the product facilitates gallbladder contraction and assists in digestive analyses while minimizing inconsistencies associated with fatty meal protocols. The company ensures consistent availability and supply, serving clients across all 50 states.Explore more
MAIA Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MAIA Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MAIA Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once MAIA Pharmaceuticals has new funding data
Earning: See what the market has to say on MAIA Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at MAIA Pharmaceuticals
Click to see if MAIA Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when MAIA Pharmaceuticals launches new products
MAIA Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if MAIA Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined MAIA Pharmaceuticals as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
MAIA Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MAIA Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MAIA Pharmaceuticals.
MAIA Pharmaceuticals financials insights
Gather financial insights about MAIA Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$130K
MAIA Pharmaceuticals News & Media
MAIA Pharmaceuticals, Inc. Announces Soterius, Inc. As Its Trusted...
Soterius to provide outsourced regulatory strategy and operations services for MAIA Pharmaceuticals, Inc. (PRWeb December 07, 2019) Read the full story at https://www.prweb.com/releases/maia_pharmaceuticals_inc_announces_soterius_inc_as_its_trusted_partner/prweb16773169.htmAthenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection
BUFFALO, N.Y., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced the launch of Levothyroxine Sodium for Injection through its subsidiary Athenex Pharmaceutical Division (APD). The APD product was brought to market in close cooperation with Princeton, NJ-based development partner, MAIA Pharmaceuticals.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding MAIA Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Fosun Pharma specializes in Sincalide for Injection, a cholecystokinin (CCK) analog used primarily in diagnostic imaging. Their Sincalide product is noteworthy for being FDA approved, having a 24-month shelf life, and contains no preservatives or polysorbates. Aimed at healthcare professionals, the product facilitates gallbladder contraction and as... Read More
